课题基金 / 基金详情

Design of hypoxic cell radiosensitizer utilized for hypoxia orientation of macrophage

Design of hypoxic cell radiosensitizer utilized for hypoxia orientation of macrophage
用于巨噬细胞缺氧定向的缺氧细胞放射增敏剂的设计
批准号:
14370758
负责人:
HORI Hitoshi
金额:
$4.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

HORI Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
我们设计了一种新型的低氧细胞放射增敏剂TX-2068,用于巨噬细胞的低氧定位。TX-2068的N-乙酰半乳糖胺部分为巨噬细胞识别基团,TX-1877部分为放射增敏基团。以N-乙酰氨基半乳糖和TX-1877为原料,以BF3为催化剂,经脱保护反应合成了TX-2068,总收率35%。TX-2068的水-辛醇分配系数(POCT)为0.0010,与TX-1877的POCT=0.056相比,具有很高的水溶解度。TX-2068的放射增敏活性与EMT6/KU细胞的增敏比(ER)=1.88(1 MM),与TX-1877的ER=1.75(1 MM)相比略有提高。通过巨噬细胞吞噬实验评价TX-2068对巨噬细胞的激活程度。结果表明,当TX-2068浓度达到1 mM时,吞噬活性增加,5 mM时,吞噬活性降低。我们认为这种行为是免疫反应中常见的钟尖型激活曲线,而TX-2068是巨噬细胞的激活。此外,用四甲基偶氮唑蓝比色法对TX-2068巨噬细胞在5 mM以下未观察到细胞毒作用。综合以上结果,我们认为TX-2068是一种具有放射增敏活性和巨噬细胞吞噬活性的双功能药物,无细胞毒性。最终完成了用于巨噬细胞低氧定位的低氧细胞放射增敏剂的设计。
英文摘要
We designed a novel hypoxic cell radiosensitizer TX-2068 that utilize for hypoxia orientation of macrophage. TX-2068 has a N-acetylgalactosamine moiety as a macrophage recognition group and TX-1877 moiety as a radiosensitizing group. We synthesized TX-2068 at condensation reaction with acetylated N-acetylgalactosamine and TX-1877 using BF3 as a catalyst followed by deprotection of O-acetyl group, TX-2068 was obtained by the total yield 35%. Water-octanol distribution coefficient (Poct) of TX-2068 was Poct = 0.0010, and a very high water solubility was shown compared with Poct = 0.056 of TX-1877. Radiosensitizing activity of TX-2068 was indicated as a enhancement ratio (ER) = 1.88 (1 mM) with EMT6/KU cell, and a little high sensitization revitalization was shown compared with ER = 1.75 (1 mM) of TX-1877. The degree of macrophage activation of TX-2068 was evaluated by macrophage phagocytic activation experiment. As a result, phagocytic activity was increased by the use of TX-2068 up to 1 mM and decreased at 5 mM. We suggested that this behavior is the bell-sharp type activation curve as a generally seen in immune reaction, and TX-2068 be activated of the macrophage. Besides, cytotoxicity for the macrophage cell of TX-2068 was not observed up to 5 mM at MTT method. From the all above-mentioned results, we concluded that TX-2068 is a bifunctional drug having radiosensitizing activity and macrophage phagocytic activity without cytotoxicity. Finally we finish the scientific research titled "Design of hypoxic cell radiosensitizer utilized for hypoxia orientation of macrophage".
期刊论文(120)
专著(0)
科研奖励(0)
会议论文
Synthesis of the new mannosidase inhibitor, diversity-oriented 5-substituted swainsonine analogues, via stereoselective Mannich reaction.
通过立体选择性曼尼希反应合成新型甘露糖苷酶抑制剂、面向多样性的 5-取代苦马豆素类似物。
DOI: --
发表时间: 2004
期刊: Organic Letters 6
影响因子: --
作者: [Yoshikawa, M., et al., Tomoya Fujita]
通讯作者: Tomoya Fujita
DOI: --
发表时间: 2004
期刊: 放射線生物研究 39
影响因子: --
作者: [堀 均]
通讯作者: 堀 均
Mohamad, S.B.: "Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation"Comp. Biochem. Physiol. A. Vol.132. 1-8 (2002)
Mohamad, S.B.:“肿瘤细胞 α-N-乙酰氨基半乳糖苷酶活性及其参与 GcMAF 相关巨噬细胞激活”Comp.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mohamad, S.B.: "Characterization of Human Gc Protein-derived Macrophage Activation Factor (GcMAF) and Its Functional Role in Macrophage Tumorcidal Activity"Adv. Exp. Med. Biol.. Vol.510. 77-82 (2003)
Mohamad, S.B.:“人 Gc 蛋白衍生的巨噬细胞激活因子 (GcMAF) 的表征及其在巨噬细胞杀肿瘤活性中的功能作用”Adv。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 47 条
    Development of boron trace drug with broad molecule pursuit and destructive power by neutron irradiation
    • 批准号:
      24659566
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      HORI Hitoshi
    • 依托单位:
    Molecular design of anticancer drug, α-NaGalase inhibitors for immunopotentiation
    • 批准号:
      10672090
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      1998
    • 负责人:
      HORI Hitoshi
    • 依托单位:
    Slow-growth/hypoxic cell-directed design of multifunctional antitumor agents
    • 批准号:
      08672561
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1996
    • 负责人:
      HORI Hitoshi
    • 依托单位:
    Design of Anti-ischemic drug based on their effects in liver mitochondria of the turtle as an anaerobiosis model.
    • 批准号:
      02671001
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1990
    • 负责人:
      HORI Hitoshi
    • 依托单位:
    国内基金
    海外基金
    Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
    • 批准号:
      81102247
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2011
    • 负责人:
      丁晨光
    • 依托单位: